Lenke R R, Levy H L
Am J Obstet Gynecol. 1982 Mar 1;142(5):548-53. doi: 10.1016/0002-9378(82)90759-1.
Untreated maternal phenylketonuria (PKU) may result in nonphenylketonuric offspring with mental retardation, microcephaly, congenital heart disease, and low birth weight. We obtained information about 34 pregnancies in which dietary therapy was instituted to lower the concentration of phenylalanine in maternal blood in an attempt to avoid fetal damage. The outcomes varied from mental normality with no evidence of fetal effect to neonatal death due to congenital heart disease. Dietary therapy with control of the maternal biochemical abnormalities is not yet of proved efficacy in preventing these fetal effects. The available data tend to support initiation of dietary therapy prior to conception for best results, but the number of cases is small and points to the need for further research.
未经治疗的母体苯丙酮尿症(PKU)可能导致非苯丙酮尿症后代出现智力发育迟缓、小头畸形、先天性心脏病和低出生体重。我们获取了34例妊娠的相关信息,在这些妊娠中采取了饮食疗法以降低母体血液中苯丙氨酸的浓度,试图避免对胎儿造成损害。结果各不相同,从智力正常且无胎儿受影响的迹象到因先天性心脏病导致新生儿死亡。控制母体生化异常的饮食疗法在预防这些胎儿影响方面的疗效尚未得到证实。现有数据倾向于支持在受孕前开始饮食疗法以获得最佳效果,但病例数量较少,表明需要进一步研究。